Governance Classic Home
Akums Drugs and Pharmaceuticals LtdPharmaceuticalsINE09XN01023Consolidated₹783.95+17.80 (+2.32%)Jun-26
Valuation
Market Cap₹12.33K Cr
TTM PE41.14x
Forward PE35.86x
PEG2.88
Book Value₹210.51
P/B3.72x
TTM EPS₹19.05
Fwd EPS₹21.85
TTM Revenue₹4.50K Cr
TTM PAT₹292.69 Cr
TTM EBITDA₹567.74 Cr
TTM EBIT₹409.04 Cr
Last Qtr PAT₹100.98 Cr
Last Qtr EBITDA₹174.69 Cr
Last Qtr EBIT₹133.62 Cr
Profitability
ROE8.83%
ROCE15.02%
TTM NPM6.50%
TTM EBITDA %12.61%
Curr OPM8.44%
Last OPM6.82%
Curr NPM—
Last NPM—
Curr EPS₹6.53
Last EPS₹5.53
Balance sheet
Equity₹30.62 Cr
Reserve₹3.28K Cr
Total Debt₹157.42 Cr
D/E0.05x
Interest %24.52%
Curr Interest₹24.76 Cr
Price / range
Close₹783.70
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+2.22%
1W+1.00%
1M+5.41%
3M+30.34%
6M+62.53%
1Y+64.89%
2Y-7.41%
3Y—
5Y—
Diwali+75.52%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue392.28+18.0%338.37368.61309.32332.441,348.74
Other Income26.1027.7329.6027.0828.56112.97
Total Income418.38+15.9%366.10398.21336.393611,461.70
Interest2.482.592.462.082.9110.04
Expenditure-359.04-19.1%-341.60-358.54-305.19-301.49-1,306.82
PBDT000000
EBITDA48.52+10.0%11.7824.6816.9044.1197.46
Depreciation-12.80-12.42-12.15-10.69-10.25-45.50
EBIT35.72+5.5%-0.6412.536.2133.8651.96
PBT59.34-0.3%21.7935.8731.2059.51148.37
Tax-14.50-6.59-7.75-7.74-14.64-36.73
Equity30.6230.6230.62030.6230.62
OPM14.185.959.0110.0916.4810.15
Net Profit44.84-0.1%15.2028.1123.4644.87111.64
NPM10.724.157.067.5912.437.64
EPS2.93+0.0%0.991.841.532.937.29

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 2 years
MetricFY 25-26FY 24-25
Revenue1,348.74+2.8%1,311.78
Other Income112.97124.19
Total Income1,461.70+1.8%1,435.98
Expenditure-1,306.82-6.4%-1,228.14
Interest-10.04-15.31
PBDT00
EBITDA97.46-29.6%138.50
Depreciation-45.50-39.55
EBIT51.96-47.5%98.95
PBT148.37-28.6%207.84
Tax-36.73-46.84
Equity30.6230.62
OPM (%)10.1514.47
Net Profit111.64-30.7%161
NPM (%)7.6411.21
EPS (Rs)7.29-32.2%10.76
CEPS7.2910.76

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue1,166.63+13.9%1,157.871,159.591,017.531,024.034,359.02
Other Income30.3835.3034.3332.3726.73128.73
Total Income1,197.01+13.9%1,193.171,193.921,049.901,050.764,487.74
Interest24.7623.8923.7423.3023.1494.07
Expenditure-1,057.77-10.7%-1,070.16-1,076.12-984.22-955.12-4,085.62
PBDT000000
EBITDA174.69+35.5%151.72146.8694.47128.97522.02
Depreciation-41.07-40.12-39.65-37.86-36.92-154.55
EBIT133.62+45.2%111.60107.2156.6192.05367.47
PBT139.24+45.6%121.2299.5765.6795.65382.10
Tax-38.26-39.87-31.89-22.98-30.96-125.70
Equity30.6230.620030.6230.62
OPM11.6310.168.346.269.108.51
Net Profit100.98+56.1%81.3467.6742.7064.69256.40
NPM8.446.825.674.076.165.71
EPS6.53+57.3%5.534.332.664.1516.67

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 2 years
MetricFY 25-26FY 24-25
Revenue4,359.02+5.8%4,118.16
Other Income128.7352.12
Total Income4,487.74+7.6%4,170.28
Expenditure-4,085.62-6.3%-3,841.72
Interest-94.07-34.60
PBDT00
EBITDA522.02+12.4%464.49
Depreciation-154.55-153.45
EBIT367.47+18.1%311.04
PBT382.10+10.7%345.25
Tax-125.70-1.48
Equity30.6230.62
OPM (%)8.518.28
Net Profit256.40-25.4%343.78
NPM (%)5.718.24
EPS (Rs)16.67-26.2%22.60
CEPS16.6722.60

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

2
YearTypeAmountEx-Date
2026Final Dividend103 Jul 2026
2026Special Dividend203 Jul 2026

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers